
Atorvastatin
Atorvastatin lowers LDL cholesterol and, in large trials, prevented heart attacks and strokes in people with high blood pressure, type 2 diabetes, coronary disease or a past stroke. Grapefruit affects it far less than simvastatin; red yeast rice, St. John's wort and cholesterol-dose niacin are the supplement combinations that matter most.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults with high LDL cholesterol, heart disease, type 2 diabetes, a past stroke or several cardiovascular risk factors, treated and monitored by a prescriber
Common dosing range
Set by your prescriber. The Lipitor label gives a starting dose of 10 or 20 mg once daily (40 mg if more than a 45 percent LDL reduction is needed) within a range of 10 to 80 mg
When to expect effects
LDL falls within weeks (the label suggests checking as early as 4 weeks); in ASCOT the drop in heart events emerged within the first year
Watch out for
Muscle injury (myopathy, rarely rhabdomyolysis) and liver enzyme rises; risk grows with higher doses and certain drug combinations. The label advises against more than 1.2 liters of grapefruit juice a day. Statins lower blood CoQ10, but evidence that CoQ10 pills relieve muscle symptoms is mixed
What is it
Atorvastatin is a prescription cholesterol-lowering medicine in the statin class, sold as Lipitor, as generic tablets, and as an oral suspension (Atorvaliq). It lowers LDL ("bad") cholesterol and reduces the risk of heart attack and stroke in adults with heart disease, type 2 diabetes or several risk factors. It covers a wide dose range (10 to 80 mg), so it is often used when a stronger LDL reduction is needed. Like simvastatin it is broken down partly by the CYP3A4 enzyme, but it is less sensitive to grapefruit and to CYP3A4-blocking drugs, which is why its label sets dose limits for many combinations rather than banning them.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
heart attack prevention in high blood pressure Strong Evidence | Large; about 36 percent fewer coronary events and 27 percent fewer strokes over 3.3 years | Adults with high blood pressure and other cardiovascular risk factors, even without high cholesterol | Benefit emerged in the first year |
intensive treatment in stable coronary disease Strong Evidence | Moderate; 22 percent fewer major cardiovascular events with 80 mg than 10 mg | People with established coronary disease | Assessed over a median 4.9 years |
cardiovascular prevention in type 2 diabetes Good Evidence | Moderate to large; 37 percent fewer major cardiovascular events | Adults with type 2 diabetes and at least one other risk factor | Assessed over a median 3.9 years |
stroke prevention after a stroke or TIA Good Evidence | Modest; 2.2 percent absolute reduction in strokes over 5 years | People after an ischemic stroke or TIA without known heart disease | Years |
heart attack prevention in high blood pressure
- Effect
- Large; about 36 percent fewer coronary events and 27 percent fewer strokes over 3.3 years
- Best fit
- Adults with high blood pressure and other cardiovascular risk factors, even without high cholesterol
- Time
- Benefit emerged in the first year
intensive treatment in stable coronary disease
- Effect
- Moderate; 22 percent fewer major cardiovascular events with 80 mg than 10 mg
- Best fit
- People with established coronary disease
- Time
- Assessed over a median 4.9 years
cardiovascular prevention in type 2 diabetes
- Effect
- Moderate to large; 37 percent fewer major cardiovascular events
- Best fit
- Adults with type 2 diabetes and at least one other risk factor
- Time
- Assessed over a median 3.9 years
stroke prevention after a stroke or TIA
- Effect
- Modest; 2.2 percent absolute reduction in strokes over 5 years
- Best fit
- People after an ischemic stroke or TIA without known heart disease
- Time
- Years
Evidence for 4 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
heart attack prevention in high blood pressure
Disease adjunctIn the lipid arm of ASCOT, 10,305 people aged 40 to 79 with high blood pressure, at least three other risk factors and average or lower cholesterol took atorvastatin 10 mg or placebo. The trial stopped early after a median 3.3 years: fatal coronary disease or non-fatal heart attack occurred in 100 people on atorvastatin versus 154 on placebo (hazard ratio 0.64), and strokes fell from 121 to 89. Deaths (185 versus 212) did not differ significantly over this short follow-up. A pooled analysis of 26 statin trials found a consistent fall of about a fifth in major vascular events per 1.0 mmol/L of LDL lowering.
Bottom line: Even a low dose prevented heart attacks in people with high blood pressure and other risk factors.
intensive treatment in stable coronary disease
Disease adjunctIn TNT, 10,001 people with stable coronary disease and LDL below 130 mg/dL were randomized to atorvastatin 80 mg or 10 mg for a median 4.9 years. Mean LDL was 77 versus 101 mg/dL. Major cardiovascular events occurred in 8.7 versus 10.9 percent (hazard ratio 0.78), but overall deaths did not differ, and persistent liver enzyme rises were more common on 80 mg (1.2 versus 0.2 percent). A meta-analysis of five trials of more versus less intensive statin therapy found a similar 15 percent further reduction in major vascular events.
Bottom line: Higher doses add protection in coronary disease, with more liver enzyme rises.
cardiovascular prevention in type 2 diabetes
Disease adjunctCARDS randomized 2,838 people aged 40 to 75 with type 2 diabetes, no prior heart disease, LDL of 160 mg/dL (4.14 mmol/L) or lower and at least one other risk factor to atorvastatin 10 mg or placebo. It stopped 2 years early for benefit: after a median 3.9 years, major cardiovascular events occurred in 83 versus 127 people, a 37 percent reduction, and stroke fell by 48 percent. The 27 percent lower death rate was not statistically significant (p=0.059).
Bottom line: Atorvastatin 10 mg prevented first heart attacks and strokes in type 2 diabetes.
stroke prevention after a stroke or TIA
Disease adjunctSPARCL enrolled 4,731 people who had a stroke or TIA in the previous 1 to 6 months, had LDL of 100 to 190 mg/dL and no known coronary disease, and gave atorvastatin 80 mg or placebo for a median 4.9 years. Strokes occurred in 11.2 versus 13.1 percent (adjusted hazard ratio 0.84), and major cardiovascular events were also reduced. Hemorrhagic strokes were more frequent on atorvastatin (55 versus 33), overall deaths were similar, and liver enzyme rises were more common.
Bottom line: High-dose atorvastatin modestly lowers repeat strokes, with a small rise in bleeding strokes.
How it works
How to take it
What to track
Bottom line: A prescriber sets the dose. Take it the same way each day and keep your medicine and supplement list current.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Myopathy and rhabdomyolysis (muscle breakdown that can damage the kidneys). Risk rises with age 65 or older, untreated low thyroid, kidney impairment, higher doses and certain drug combinations, including cholesterol-dose niacin, fibrates and colchicine.
Immune-mediated necrotizing myopathy, a rare autoimmune muscle disease that can continue after the statin is stopped
Liver enzyme rises (persistent increases above 3 times normal in about 0.7 percent) and rare liver failure; people who drink substantial amounts of alcohol or have liver disease may be at higher risk
Small increases in HbA1c and fasting blood sugar
In SPARCL, more hemorrhagic strokes on 80 mg than placebo (55 versus 33) in people with a recent stroke or TIA
Who should avoid it
- People with acute liver failure or decompensated cirrhosis (contraindicated)
- People with a past allergic reaction to atorvastatin (contraindicated)
- People taking cyclosporine, gemfibrozil, tipranavir with ritonavir, or glecaprevir with pibrentasvir (combination not recommended)
- Pregnant people, unless their doctor has weighed the ongoing need (the label says to stop atorvastatin when pregnancy is recognized or to weigh the individual need)
- People who are breastfeeding: the label says breastfeeding is not recommended during treatment
Pregnancy & breastfeeding
The label says atorvastatin may cause fetal harm based on how it works, and tells prescribers to stop it when pregnancy is recognized or to weigh the patient's ongoing needs; cholesterol treatment is generally not needed during pregnancy. Decades of observational data have not shown a higher rate of major birth defects with statins. Breastfeeding is not recommended during treatment. If you are pregnant, planning a pregnancy or breastfeeding, talk to your doctor.
Interactions
The Lipitor label reports myopathy and rhabdomyolysis when cholesterol-dose niacin is combined with atorvastatin and asks prescribers to weigh the benefit. In HPS2-THRIVE, adding 2 g of extended-release niacin (with laropiprant) to a statin (simvastatin) raised definite myopathy about 4-fold and did not significantly reduce major vascular events (13.2 versus 13.7 percent). Do not add high-dose niacin without your prescriber; the small amounts in a multivitamin are a different matter.
St. John's wort speeds up CYP3A4, which breaks down atorvastatin. In 16 people with high cholesterol on a stable atorvastatin dose, LDL cholesterol was 2.66 mmol/L (about 103 mg/dL) after 4 weeks of St. John's wort (300 mg twice daily) versus 2.34 mmol/L (about 90 mg/dL) after 4 weeks on a control tablet. Ask your doctor or pharmacist before using it.
Red yeast rice contains monacolin K, the same molecule as the statin lovastatin, in amounts that ranged from 0.10 to 10.09 mg per capsule in 12 products, some also containing the toxin citrinin. Taking it with atorvastatin means taking two statins, which adds to the risk of muscle and liver injury; the Lipitor label lists other lipid-lowering therapies among the risk factors for muscle injury. Do not combine them without your prescriber's agreement.
These raise atorvastatin levels or add their own muscle risk, and the Lipitor label recommends against combining them with atorvastatin. Your prescriber will choose a different plan.
These block CYP3A4 or liver transporters and raise atorvastatin levels. The label caps atorvastatin at 20 mg a day with clarithromycin, itraconazole, saquinavir plus ritonavir, darunavir plus ritonavir, fosamprenavir (with or without ritonavir), elbasvir plus grazoprevir, or letermovir, and at 40 mg with nelfinavir. Unlike simvastatin, where these drugs are contraindicated, atorvastatin can often continue at a lower dose your prescriber sets.
Seville orange juice contains the same CYP3A4-blocking furanocoumarins as grapefruit. In 10 volunteers, a glass raised levels of felodipine, another CYP3A4 drug, by 76 percent compared with ordinary orange juice (dilute grapefruit juice: 93 percent). It has not been tested with atorvastatin itself. With grapefruit juice, 300 mL a day raised atorvastatin levels only 19 to 26 percent with no change in cholesterol, liver or muscle tests, so Seville orange is rated the same as grapefruit: keep it occasional and review it with your doctor or pharmacist.
Grapefruit raises atorvastatin levels less than it raises simvastatin. Very large amounts (200 mL of double-strength juice three times a day) raised atorvastatin acid exposure 2.5-fold, while 300 mL a day for 90 days in patients raised levels 19 to 26 percent with no change in cholesterol or muscle and liver tests. The Lipitor label advises against more than 1.2 liters of grapefruit juice a day.
Lab studies suggested pomegranate might block CYP3A4, but in 12 healthy men, 900 mL of pomegranate juice a day did not significantly change levels of simvastatin, a statin more sensitive to CYP3A4 than atorvastatin. Atorvastatin itself and concentrated pomegranate extracts were not tested, so mention them to your pharmacist.
The Lipitor label says people who drink substantial amounts of alcohol or have a history of liver disease may be at higher risk of liver injury on atorvastatin. Light drinking is not addressed. Discuss your drinking with your doctor, and report yellow skin or eyes or dark urine.
Bergamot is the source of bergamottin, a CYP3A4-blocking furanocoumarin. In rats with high cholesterol, bergamottin roughly tripled atorvastatin exposure (AUC from 176 to 552) and deepened its cholesterol lowering. There are no human studies, so review bergamot supplements with your doctor or pharmacist before combining.
Fibrates and colchicine can cause muscle problems on their own, and the label reports myopathy and rhabdomyolysis when they are combined with atorvastatin. Prescribers weigh the benefit and watch for muscle symptoms, especially when starting or raising either drug.
Two weeks of berberine 300 mg three times a day modestly blocked CYP3A4 in healthy men (midazolam levels rose about 40 percent), so a rise in atorvastatin levels is possible. Trials combining berberine with a statin (simvastatin) did not show more muscle aches or liver enzyme rises, but no human study has measured atorvastatin levels with berberine. Review it with your doctor or pharmacist first.
Statins lower blood CoQ10; a meta-analysis found atorvastatin lowered plasma CoQ10 by about 0.41 micromol/L. Whether CoQ10 supplements ease statin muscle aches is unsettled: one meta-analysis of 12 trials found less muscle pain, another of 7 trials found no benefit. This is not a harmful combination; if you have muscle symptoms, talk to your prescriber.
In 16 patients on atorvastatin, vitamin D 800 IU a day for 6 weeks lowered atorvastatin blood levels, yet LDL cholesterol also fell (from 97 to 83 mg/dL). In this small study, the statin's cholesterol lowering was not weakened. Tell your prescriber if you start high-dose vitamin D so your lipids can be checked as planned.
In mice, taking oat bran at the same time as a low dose of atorvastatin halved the statin's cholesterol-lowering effect, possibly by blocking its absorption; at a higher statin dose, adding oat bran made no significant difference. This has not been tested in people. Ask your pharmacist whether to space a large oat-fiber supplement apart from your dose.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (8)
+ niacin
highAdding cholesterol-dose niacin to atorvastatin raises the risk of muscle injury (myopathy, rarely rhabdomyolysis) without improving cardiovascular outcomes in patients already well treated with a statin.
+ red yeast rice
highRed yeast rice naturally contains monacolin K, the same compound as the prescription statin lovastatin. Taking it alongside atorvastatin effectively stacks two statins working through the same liver pathway, raising the risk of statin-associated muscle symptoms, rhabdomyolysis, and liver injury.
+ st. john's wort
highSt. John's wort induces CYP3A4, the enzyme that metabolizes atorvastatin, which is expected to lower statin exposure; in a human trial, LDL and total cholesterol rose when it was added to atorvastatin.
+ grapefruit
moderateGrapefruit can modestly raise atorvastatin levels through CYP3A4 inhibition. Occasional servings are usually fine; large or daily intake deserves caution.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I have grapefruit with atorvastatin?⌄
In moderation, probably yes, but check with your doctor or pharmacist. Grapefruit raises atorvastatin levels much less than simvastatin levels: in patients drinking 300 mL a day for 90 days, levels rose 19 to 26 percent with no change in cholesterol or muscle and liver tests. The Lipitor label advises against more than 1.2 liters of grapefruit juice a day.
Can I take red yeast rice or niacin with atorvastatin?⌄
Not without your prescriber's agreement. Red yeast rice contains monacolin K, which is chemically the same as the statin lovastatin, so it doubles up on statin treatment. Cholesterol-dose niacin (1 gram a day or more) raises the risk of muscle injury with statins and, in a large trial, did not significantly reduce heart attacks, strokes and related events when added to a statin.
Does atorvastatin deplete CoQ10?⌄
Yes, statins lower CoQ10 in the blood; pooled trials found a fall of about 0.41 micromol/L with atorvastatin. Whether CoQ10 supplements help statin muscle aches is unclear, because meta-analyses disagree. If you have muscle symptoms, ask your doctor to look for causes and discuss options; do not stop atorvastatin on your own.
Is vitamin D safe with atorvastatin?⌄
In a small study, vitamin D 800 IU a day lowered atorvastatin blood levels, but LDL cholesterol fell rather than rose. In this small study, the statin's cholesterol lowering was not weakened. If you take high-dose vitamin D, tell your prescriber so your lipid checks can be planned.
Does it matter what time of day I take atorvastatin?⌄
No. The Lipitor label says it can be taken once daily at any time, with or without food; LDL lowering is the same morning or evening. If you miss a dose, the label says to skip it and take the next one at the usual time.
How is atorvastatin different from simvastatin for interactions?⌄
Both are broken down by CYP3A4, but simvastatin is much more sensitive. With the same large grapefruit regimen in two small studies, the active acid form of simvastatin rose about 7-fold and that of atorvastatin 2.5-fold. Strong CYP3A4-blocking antibiotics and antifungals are contraindicated with simvastatin, while the atorvastatin label sets dose limits instead. Your pharmacist can check any specific combination.
References by claim
heart attack prevention in high blood pressure
cardiovascular prevention in type 2 diabetes
Colhoun et al., 2004 · PubMed (2004) link
intensive treatment in stable coronary disease
LaRosa et al., 2005 · PubMed (2005) link
stroke prevention after a stroke or TIA
Amarenco et al., 2006 · PubMed (2006) link
Safety
Lipitor (atorvastatin calcium) tablets prescribing information · DailyMed (FDA label) link
Interaction: Seville (bitter) orange and its juice
Interaction: Niacin at cholesterol-lowering doses (1 gram a day or more)
Interaction: St. John's wort
Andrén et al., 2007 · PubMed (2007) link
Interaction: Red yeast rice
Gordon et al., 2010 · PubMed (2010) link
Interaction: Grapefruit and grapefruit juice
Lilja et al., 1999 · PubMed (1999) link
Interaction: Coenzyme Q10 (CoQ10)
Interaction: Vitamin D
Schwartz et al., 2009 · PubMed (2009) link
Interaction: Pomegranate and pomegranate juice
Park et al., 2016 · PubMed (2016) link
Interaction: Oat fiber and oat bran
Eussen et al., 2011 · PubMed (2011) link
Interaction: Bergamot (bergamot juice, bergamot polyphenol supplements)
Zhang et al., 2022 · PubMed (2022) link
Track Atorvastatin with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
